Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · IEX Real-Time Price · USD
7.09
+0.03 (0.42%)
At close: Jul 19, 2024, 4:00 PM
7.20
+0.11 (1.55%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Cabaletta Bio Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Cabaletta Bio stock have an average target of 35.78, with a low estimate of 25 and a high estimate of 50. The average target predicts an increase of 404.65% from the current stock price of 7.09.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 21, 2024.
Analyst Ratings
The average analyst rating for Cabaletta Bio stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 5 | 5 | 5 | 5 | 5 |
| Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 8 | 8 | 8 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $50 | Buy | Reiterates | $50 | +605.22% | Jun 21, 2024 |
| Stifel | Stifel | Strong Buy Maintains $32 | Strong Buy | Maintains | $32 | +351.34% | Jun 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +323.13% | Jun 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +323.13% | May 24, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +323.13% | May 16, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
8.50M
EPS This Year
-2.18
from -1.65
EPS Next Year
-2.23
from -2.18
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 52.5M | 15.8M | 240.5M | 735.0M |
| Avg | n/a | 8.5M | 3.1M | 72.0M | 253.5M |
| Low | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 85.3% | 7,757.8% | 921.4% |
| Avg | - | - | -64.0% | 2,251.7% | 252.3% |
| Low | - | - | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.92 | -1.04 | -1.97 | -0.44 | 3.39 |
| Avg | -2.18 | -2.23 | -2.52 | -0.96 | 1.06 |
| Low | -2.33 | -2.82 | -3.08 | -1.64 | -2.05 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.